It is a short peptide in which the copper atom is attached between the histidine and alanine residues of the alanine-histidine-lysine tripeptide
Every individuals medical history, existing conditions, and current medications can affect how this medication works
Provides localized, extended-release delivery with no injection site trauma
This surgery is newer and was not approved until 2001
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
Research Insights NNMT & Obesity Pathways NNMT has been identified as a key regulator of adipose tissue metabolism
